 |
Clinical Trials & Research in DenverIntermountain Health Heart and Vascular is recognized nation-wide for advancing cardiology and heart surgery through research and clinical trials. As a regional leader in cardiovascular care, including top-rated structural heart and cardiothoracic surgery programs, Saint Joseph Hospital was the only hospital in Colorado selected to participate in the MitraClip Repair MR Study, and the only hospital in Denver to participate in the Edwards PASCAL Transcatheter Valve Repair System Pivotal Clinical Trial (CLASP II TR). 
|
Aortic Stenosis TrialThe ENVISION Clinical Trial is studying Transcatheter Aortic Valve Implantation (TAVI) Systems in patients with severe, symptomatic aortic stenosis who are deemed low or intermediate surgical risk. 
|
Bradycardia Pacemaker with AV Interval Modulation for Blood PressureAs a leader in electrophysiology, our hospitals are participating in a prospective, multinational, randomized, double-blind, clinical trial evaluating the safety and effectiveness of a novel atrioventricular interval modulation (AVIM) algorithm downloaded into a dual-chamber Medtronic Astra/Azure pacemaker. 
|
Coronary Artery Disease (CAD) Staging SystemLed by Dr. Angus, this trial evaluates patients who are at increased risk for atherosclerotic cardiovascular (CV) disease but with no known symptomatic CV disease, and strategies that could reduce cardiovascular events compared with risk factor-based care. 
|
MitraClip REPAIR MR StudyIntermountain Health has several sites participating in a randomized controlled trial to compare the clinical outcome of MitraClip™ device versus surgical repair in patients with severe primary Mitral Regurgitation. This trial seeks to compare outcomes for intermediate risk patients treated with either MitraClip versus surgery for primary (degenerative), severe MR. 
|
Randomized Comparison of Personalized Management for Medical and Interventional Therapy Based On Coronary Atherosclerotic Plaque Versus Usual Care for Symptomatic Patients With Suspicion of CADLed by Dr. Angus, this is a randomized open-label trial testing the hypothesis that a personalized management strategy in symptomatic patients with suspicion of coronary artery disease (CAD), using a CT-based coronary atherosclerotic plaque assessment by AI-enabled quantitative software. 
|
Transcatheter Valve Repair System Pivotal Clinical Trial (CLASP II TR)Saint Joseph Hospital is participating in the multicenter, controlled pivotal trial to evaluate transcatheter tricuspid valve repair with the Edwards PASCAL Transcatheter Valve Repair System and optimal medical therapy in patients with tricuspid regurgitation. 
|